Literature DB >> 3866254

Vasoactive intestinal polypeptide acts synergistically with norepinephrine to depress spontaneous discharge rate in cerebral cortical neurons.

A Ferron, G R Siggins, F E Bloom.   

Abstract

Cortical neurons are densely innervated by noradrenergic fibers and by intrinsic cortical interneurons containing vasoactive intestinal polypeptide (VIP). Biochemically, VIP and norepinephrine (NE) synergistically interact to stimulate the synthesis of cyclic AMP in cortical slices. Therefore, we sought physiological indices of this peptide-monoamine interaction by applying VIP and NE to single cortical neurons of the rat while recording their spontaneous discharge. VIP applied alone inhibited discharge of 24% and accelerated discharge in 20% of cortical neurons. NE alone had a predominantly depressant effect on the same neurons. However, when VIP was retested during the continuous application of subthreshold currents of NE, VIP exerted predominantly depressant effects. These synergistic inhibitions resulted even in cells previously showing excitations to VIP alone. If VIP alone was depressant, subthreshold NE further enhanced the VIP depression. Subthreshold amounts of phenylephrine, an alpha-adrenoceptor agonist, also produced comparable interactions, suggesting involvement of an alpha receptor, as in the biochemical studies. These results support a peptide-monoamine interaction in cortex that could have important ramifications for neuronal integration.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3866254      PMCID: PMC391527          DOI: 10.1073/pnas.82.24.8810

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

Review 1.  Cyclic nucleotides and nervous system function.

Authors:  J A Nathanson
Journal:  Physiol Rev       Date:  1977-04       Impact factor: 37.312

2.  Vasoactive intestinal polypeptide: specific binding to rat brain membranes.

Authors:  D P Taylor; C B Pert
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

3.  Distribution of vasoactive intestinal polypeptide in the rat and mouse brain.

Authors:  I Lorén; P C Emson; J Fahrenkrug; A Björklund; J Alumets; R Håkanson; F Sundler
Journal:  Neuroscience       Date:  1979       Impact factor: 3.590

Review 4.  Peptidergic neurones.

Authors:  T Hökfelt; O Johansson; A Ljungdahl; J M Lundberg; M Schultzberg
Journal:  Nature       Date:  1980-04-10       Impact factor: 49.962

5.  Effect of vasoactive intestinal peptide (VIP) and other peptides on cAMP accumulation in rat brain.

Authors:  M Quik; L L Iversen; S R Bloom
Journal:  Biochem Pharmacol       Date:  1978       Impact factor: 5.858

6.  Vasoactive intestinal polypeptide excitation of central neurons.

Authors:  J W Phillis; J R Kirkpatrick; S I Said
Journal:  Can J Physiol Pharmacol       Date:  1978-04       Impact factor: 2.273

7.  Potentiation of alpha 1-adrenergic responses in rat liver by a cAMP-dependent mechanism.

Authors:  N G Morgan; R Charest; P F Blackmore; J H Exton
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

8.  Catecholamine modulation of enkephalin-induced electrophysiological responses in cerebral cortex.

Authors:  M R Palmer; B J Hoffer
Journal:  J Pharmacol Exp Ther       Date:  1980-05       Impact factor: 4.030

9.  Vasoactive intestinal polypeptide in brain: localization in and release from isolated nerve terminals.

Authors:  A Giachetti; S I Said; R C Reynolds; F C Koniges
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

10.  Vasoactive intestinal polypeptide (VIP): vesicular localization and potassium evoked release from rat hypothalamus.

Authors:  P C Emson; J Fahrenkrug; O B Schaffalitzky de Muckadell; T M Jessell; L L Iversen
Journal:  Brain Res       Date:  1978-03-17       Impact factor: 3.252

View more
  6 in total

1.  Systemic phenoxybenzamine but not beta-adrenergic antagonists block noradrenergic inhibition of cerebellar Purkinje and hippocampal pyramidal neurons.

Authors:  D A Staunton; T H Svensson; G E Chouvet; G R Siggins; F E Bloom
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

Review 2.  VIP as a cell-growth and differentiation neuromodulator role in neurodevelopment.

Authors:  J M Muller; V Lelievre; L Becq-Giraudon; A C Meunier
Journal:  Mol Neurobiol       Date:  1995 Apr-Jun       Impact factor: 5.590

3.  Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide-stimulated cyclic AMP synthesis in rat cerebral cortical slices: interaction with noradrenaline, adrenaline, and forskolin.

Authors:  Jerzy Z Nowak; Katarzyna Kuba
Journal:  J Mol Neurosci       Date:  2002 Feb-Apr       Impact factor: 3.444

Review 4.  VIP: molecular biology and neurobiological function.

Authors:  I Gozes; D E Brenneman
Journal:  Mol Neurobiol       Date:  1989       Impact factor: 5.590

5.  Somatostatin selectively enhances acetylcholine-induced excitations in rat hippocampus and cortex.

Authors:  J R Mancillas; G R Siggins; F E Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

6.  VIP receptors control excitability of suprachiasmatic nuclei neurones.

Authors:  Pavel Pakhotin; Anthony J Harmar; Alexei Verkhratsky; Hugh Piggins
Journal:  Pflugers Arch       Date:  2005-11-08       Impact factor: 3.657

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.